200 related articles for article (PubMed ID: 28455658)
1. Hemodialysis is associated with higher serum FGF23 level when compared with peritoneal dialysis.
Bi S; Liang Y; Cheng L; Wang Y; Wang T; Han Q; Zhang A
Int Urol Nephrol; 2017 Sep; 49(9):1653-1659. PubMed ID: 28455658
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
Isakova T; Xie H; Barchi-Chung A; Vargas G; Sowden N; Houston J; Wahl P; Lundquist A; Epstein M; Smith K; Contreras G; Ortega L; Lenz O; Briones P; Egbert P; Ikizler TA; Jueppner H; Wolf M
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2688-95. PubMed ID: 21903990
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
[TBL] [Abstract][Full Text] [Related]
4. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
Sugimoto H; Ogawa T; Iwabuchi Y; Otsuka K; Nitta K
Int Urol Nephrol; 2014 Jan; 46(1):99-106. PubMed ID: 23355029
[TBL] [Abstract][Full Text] [Related]
6. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Relationship Between Blood Pressure and Serum FGF23 Level in Patients Undergoing Hemodialysis in Guilan Province, A Cross Sectional Study.
Ramezanzade E; Minoo F; Lebadi MK; Jedinia A; Saheli YH; Aghajanzadeh P; Monfared A; Khosravi M
Iran J Kidney Dis; 2019 Jul; 13(4):262-268. PubMed ID: 31422393
[TBL] [Abstract][Full Text] [Related]
8. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
[TBL] [Abstract][Full Text] [Related]
9. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Ohya M; Yashiro M; Sonou T; Okuda K; Tatsuta K; Mima T; Tone Y; Negi S; Saika Y; Shigematsu T
Contrib Nephrol; 2018; 196():44-51. PubMed ID: 30041203
[TBL] [Abstract][Full Text] [Related]
11. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
[TBL] [Abstract][Full Text] [Related]
12. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
[TBL] [Abstract][Full Text] [Related]
13. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients.
Urena Torres P; Friedlander G; de Vernejoul MC; Silve C; Prié D
Kidney Int; 2008 Jan; 73(1):102-7. PubMed ID: 17943081
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients.
Chen Z; Chen X; Xie J; Ma X; Zhong F; Hou L; Ling H; Li X; Ren H; Chen N
Ren Fail; 2013; 35(5):660-6. PubMed ID: 23581403
[TBL] [Abstract][Full Text] [Related]
15. Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.
Asamiya Y; Yajima A; Shimizu S; Otsubo S; Tsuchiya K; Nitta K
Osteoporos Int; 2015 Mar; 26(3):1017-28. PubMed ID: 25366373
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
[TBL] [Abstract][Full Text] [Related]
17. Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients.
Chang YM; Tsai SC; Shiao CC; Liou HH; Yang CL; Tung NY; Hsu KS; Chen IL; Liu MC; Kao JL; Jhen RN; Huang YT
Clin Exp Nephrol; 2017 Oct; 21(5):908-916. PubMed ID: 27928636
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism.
Kuczera P; Adamczak M; Wiecek A
Clin Endocrinol (Oxf); 2014 Apr; 80(4):607-12. PubMed ID: 24111496
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
20. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
